xeljanz
pfizer europe ma eeig - tofacitinib - artritis, reumatoïde - immunosuppressiva - rheumatoid arthritistofacitinib in combination with methotrexate (mtx) is indicated for the treatment of moderate to severe active rheumatoid arthritis (ra) in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying antirheumatic drugs (dmards) (see section 5. tofacitinib can be given as monotherapy in case of intolerance to mtx or when treatment with mtx is inappropriate (see sections 4. 4 en 4. psoriatic arthritistofacitinib in combination with mtx is indicated for the treatment of active psoriatic arthritis (psa) in adult patients who have had an inadequate response or who have been intolerant to a prior disease modifying antirheumatic drug (dmard) therapy (see section 5. ulcerative colitistofacitinib is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (uc) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biologic agent (see section 5. tofacitinib is indicated for the treatment of active polyarticular juvenile idiopathic arthritis (rheumatoid factor positive [rf+] or negative [rf-] polyarthritis and extended oligoarthritis), and juvenile psoriatic arthritis (psa) in patients 2 years of age and older, who have responded inadequately to previous therapy with disease modifying antirheumatic drugs (dmards). tofacitinib can be given in combination with methotrexate (mtx) or as monotherapy in case of intolerance to mtx or where continued treatment with mtx is inappropriate. ankylosing spondylitistofacitinib is indicated for the treatment of adult patients with active ankylosing spondylitis (as) who have responded inadequately to conventional therapy.
apoquel
zoetis belgium sa - oclacitinibmaleaat - middelen voor dermatitis, met uitzondering van corticosteroïden - honden - - treatment of pruritus associated with allergic dermatitis in dogs. - treatment of clinical manifestations of atopic dermatitis in dogs.
apoquel 16 mg filmomhulde tabletten voor honden
zoetis belgium - oclacitinibmaleaat; oclacitinib - tablet - oclacitinibmaleaat 21,5 mg/stuk; oclacitinib 16 mg/stuk, - oclacitinib - honden
apoquel 16 mg kauwtabletten voor honden
zoetis belgium s.a. vmrd - oclacitinibmaleaat; oclacitinib - kauwtablet - oclacitinibmaleaat 21,502 mg/stuk; oclacitinib 16 mg/stuk, - oclacitinib - honden
apoquel 3,6 mg filmomhulde tabletten voor honden
zoetis belgium - oclacitinibmaleaat; oclacitinib - tablet - oclacitinibmaleaat 4,8 mg/stuk; oclacitinib 3,6 mg/stuk, - oclacitinib - honden
apoquel 3,6 mg kauwtabletten voor honden
zoetis belgium s.a. vmrd - oclacitinibmaleaat; oclacitinib - kauwtablet - oclacitinibmaleaat 4,838 mg/stuk; oclacitinib 3,6 mg/stuk, - oclacitinib - honden
apoquel 5,4 mg filmomhulde tabletten voor honden
zoetis belgium - oclacitinibmaleaat; oclacitinib - tablet - oclacitinibmaleaat 7,3 mg/stuk; oclacitinib 5,4 mg/stuk, - oclacitinib - honden
apoquel 5,4 mg kauwtabletten voor honden
zoetis belgium s.a. vmrd - oclacitinibmaleaat; oclacitinib - kauwtablet - oclacitinibmaleaat 7,257 mg/stuk; oclacitinib 5,4 mg/stuk, - oclacitinib - honden
prolevare 16 mg filmomhulde tabletten voor honden
zoetis belgium - oclacitinibmaleaat - filmomhulde tablet - oclacitinibmaleaat 21,502 mg/stuk - oclacitinib - honden
prolevare 3,6 mg filmomhulde tabletten voor honden
zoetis belgium - oclacitinibmaleaat - filmomhulde tablet - oclacitinibmaleaat 4,838 mg/stuk - oclacitinib - honden